ARTICLE | Emerging Company Profile

Pfenex: Pfaster protein production

January 18, 2010 8:00 AM UTC

Pfenex Inc. believes its protein expression technology can produce functional human proteins at a much faster rate and higher yield than current systems. Instead of taking a stepwise approach, the spinout from Dow Chemical Co. uses algorithms to simultaneously modify multiple factors to produce an expression vector and optimized protein product in the least amount of time.

Also, unlike proteins produced in Escherichia coli, those produced in the biotech's Psdeudomonas fluorescens-based system do not require further processing of proteins after expression...